North America Diabetes

• Latin America Continuous Glucose Monitoring Device Market, By Component (Transmitters, Receivers, Insulin Pump, and Sensors ), by Distribution Channel (Hospitals & Clinics, Retail Channel, and Online Channel), and by Country (Mexico, Argentina, Uruguay, B

  May 07, 2022  |  Published by: Coherent Market Insights  |  USD 4,500

  ... Chile, Peru, and Rest of Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Continuous glucose monitoring devices are considered as significant systems for improving diabetes management by providing better and pain-free ... Read More

• North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)

  Apr 20, 2022  |  Published by: The Insight Partners  |  USD 3,000

  ... (Patients, Providers, Payers, and Employers) The North America digital therapeutics market is expected to reach US$ 7,323.29 million by 2028 from US$ 1,740.46 million in 2021; it is estimated to grow at a CAGR of ... Read More

• North America Diabetic Footwear Market Databank

  Apr 01, 2022  |  Published by: Magna Intelligence  |  USD 1,500

  ... 2029. Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment is ... Read More

• Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025

  Mar 17, 2022  |  Published by: Daedal Research  |  USD 950

  ... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More

• U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028

  Mar 04, 2022  |  Published by: Global Market Insights  |  USD 3,750

  ... Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 The U.S. clinical ... Read More

• North America Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Country and Growth Forecast, 2021 - 2027

  Feb 28, 2022  |  Published by: Knowledge Based Value (KBV) Research  |  USD 1,500

  ... The North America Insulin Syringes Market would witness market growth of 3.0% CAGR during the forecast period (2021-2027). Diabetic people are more susceptible to COVID-19 infection and hence seek good glycemic management. As a result ... Read More

• Canada Insulin Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  Jan 24, 2022  |  Published by: Mordor Intelligence Inc  |  USD 4,750

  ... CAGR of about 3.5% during the forecast period (2022 - 2027). Diabetes is one of the top chronic and life-threatening diseases affecting Canadians. The negative effects of COVID-19 on people with diabetes have underscored the ... Read More

• NORTH AMERICA DIPEPTIDE PEPTIDASE 4 (DPP-4) INHIBITORS Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  Jan 17, 2022  |  Published by: Mordor Intelligence Inc  |  USD 4,750

  ... drug market and is expected to witness the steady CAGR of 1.3%. The North American DPP-4 drugs segment of the market studied accounted for the highest revenue in 2017. It is estimated that within the ... Read More

• The Market for In Vitro Diagnostic Tests in Latin America

  Jun 01, 2021  |  Published by: Kalorama Information  |  USD 4,000

  ... (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are ... Read More

• US Blood Glucose Monitoring Systems Market Report

  Feb 20, 2016  |  Published by: ABMRG  |  USD 1,800

  ... report include: Traditional Glucose Monitoring Continuous Glucose Monitoring (CGM) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. Highlights ... Read More

< prev 1 2 3 4 5 next >